These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3308587)

  • 41. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-human pancreas as substrate for cytoplasmic islet cell antibodies.
    Mozaffarian N; McCulloch DK; Palmer JP
    Diabetes Res Clin Pract; 1991 Jan; 11(1):33-9. PubMed ID: 2019233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM.
    Brown FM; Kamalesh M; Adri MN; Rabinowe SL
    Diabetes Care; 1988 Jan; 11(1):30-3. PubMed ID: 3276475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
    Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
    Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
    Verge CF; Stenger D; Bonifacio E; Colman PG; Pilcher C; Bingley PJ; Eisenbarth GS
    Diabetes; 1998 Dec; 47(12):1857-66. PubMed ID: 9836516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
    Karjalainen JK
    Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies against bovine albumin and other diabetes markers in French children.
    Lévy-Marchal C; Karjalainen J; Dubois F; Karges W; Czernichow P; Dosch HM
    Diabetes Care; 1995 Aug; 18(8):1089-94. PubMed ID: 7587842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes].
    Bieg S; Seissler J; Scherbaum WA
    Med Klin (Munich); 1995 Oct; 90(10):594-8. PubMed ID: 7500923
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of an immunohistochemical and immunofluorescence procedure to detect antibody to pancreatic islet cells.
    Krell J; Rabin BS
    Diabetes; 1984 Aug; 33(8):709-11. PubMed ID: 6204895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of islet cell antibodies on frozen sections of human pancreas.
    Marner B; Lernmark A; Nerup J; Molenaar JL; Tuk CW; Bruining GJ
    Diabetologia; 1983 Aug; 25(2):93-6. PubMed ID: 6354815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reevaluation of autoantibodies to islet cell membrane in IDDM. Failure to detect islet cell surface antibodies using human islet cells as substrate.
    Vives M; Somoza N; Soldevila G; Gomis R; Lucas A; Sanmarti A; Pujol-Borrell R
    Diabetes; 1992 Dec; 41(12):1624-31. PubMed ID: 1446804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
    Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
    Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pancreatic islet cells in tissue culture: function and immunoreactivity with serum autoantibodies from diabetes type-1 patients and monoclonal antibodies ICA-1.
    Zlobina EN; Rossels AN; Yesenin VI; Demin YM; Bachurin PS; Filatov AV; Brikova SV
    Exp Clin Endocrinol; 1989 May; 93(2-3):161-5. PubMed ID: 2673809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
    Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
    Mustonen A; Knip M; Akerblom HK
    Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Islet-cell, thyroid, and gastric autoantibodies in diabetic identical twins.
    Lendrum R; Nelson PG; Pyke DA; Walker G; Gamble DR
    Br Med J; 1976 Mar; 1(6009):553-5. PubMed ID: 769892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.
    Lan MS; Wasserfall C; Maclaren NK; Notkins AL
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6367-70. PubMed ID: 8692821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies.
    Maugendre D; Chaillous L; Rohmer V; Lecomte P; Marechaud R; Saï P; Marre M; Charbonnel B; Allannic H; Delamaire M
    Diabetes Metab; 1997 Sep; 23(4):320-6. PubMed ID: 9342546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes.
    Dotta F; Gianani R; Previti M; Lenti L; Dionisi S; D'Erme M; Eisenbarth GS; Di Mario U
    Diabetes; 1996 Sep; 45(9):1193-6. PubMed ID: 8772721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.